# Patiromer Versus Placebo to Enable Spironolactone Use in Patients with Resistant Hypertension and Chronic Kidney Disease ( <b>AMBER</b> ): Results in the Pre-Specified Subgroup with Heart Failure

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/patiromer-versus-placebo-to-enable-spironolactone-use-in-patients-with-resistant-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Patrick Rossignol,Bryan Williams,Martha Mayo,Suzette Warren,Susan Arthur,Gail Ackourey,William B. White,Rajiv Agarwal |
| Citations | 54 |
| DOI | 10.1002/ejhf.1860 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejhf.1860 |
| OpenAlex ID | https://openalex.org/W3031829024 |
| PMID | 32452085 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Patrick Rossignol](https://scholariq.org/researchers/patrick-rossignol-2/)
- [Bryan Williams](https://scholariq.org/researchers/bryan-williams/)
- [William B. White](https://scholariq.org/researchers/william-b-white/)
- [Martha Mayo](https://scholariq.org/researchers/martha-mayo/)
- [Rajiv Agarwal](https://scholariq.org/researchers/rajiv-agarwal/)

## Paper funders

- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [European Society of Cardiology](https://scholariq.org/funders/european-society-of-cardiology/)
- [Vifor Pharma](https://scholariq.org/funders/vifor-pharma/)
- [Idorsia Pharmaceuticals](https://scholariq.org/funders/idorsia-pharmaceuticals/)
- [Medical Research Council](https://scholariq.org/funders/medical-research-council/)
- [Relypsa](https://scholariq.org/funders/relypsa/)

## Paper journal

- [European Journal of Heart Failure](https://scholariq.org/journals/european-journal-of-heart-failure/)

## Paper primary topic

- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)

## Paper topics

- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.